Revisión clínica

← vista completa

Publicado el 1 de diciembre de 2008 | http://doi.org/10.5867/medwave.2008.11.3669

Micosis invasiva

Invasive fungal infection

María Isabel Guango, Giovanna Santander Luna, Nelson Villamarín Salgado

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Compartir

Autores

María Isabel Guango

Médico postgradista Universidad San Francisco de Quito, Ecuador
Hospital Carlos Andrade Marín, Ecuador

Giovanna Santander Luna

Médico cirujano, Pontificia Universidad Católica del Ecuador, Diplomada en Medicina Basada en la Evidencia
Directora médica Laboratorios Recalcine, Ecuador

Nelson Villamarín Salgado

Médico tratante del Servicio de Terapia Intensiva del Hospital Carlos Andrade Marín, Especialista en Medicina Crítica, Universidad Técnica Particular de Loja, diplomado superior en docencia universitaria Pontificia Universidad Católica del Ecuador.

Figures

Article has no figures.

Foro

Comentar

Para comentar es necesario iniciar sesión.
Iniciar sesión / Registrarse

Comentarios

Historial

Citación Guango MI, Santander Luna G, Villamarín Salgado N. Invasive fungal infection. Medwave 2008;8(11):e3669 doi: 10.5867/medwave.2008.11.3669

Publicación 01/12/2008

Article metrics

HTML Views

2197

PDF Downloads

PDF Download %

0.0%

Total

2197

See more

Notas

Provenance and peer review

sin revisión por pares

Referencias

  1. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in non neutropenic critically ill patients with Candida colonization. Crit Care Med. 2006 Mar;34(3):730-7. | CrossRef | PubMed
  2. Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006 Mar;34(3):857-63. | CrossRef | PubMed
  3. Dean DA, Burchard KW. Surgical Perspective on Invasive Candida Infections, World J Surg. 1998 Feb;22(2):127-34. | CrossRef | PubMed
  4. Philippe Eggimann, Jorge Garbino, and Didier Pittet. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003 Nov;3(11):685-702. | CrossRef | PubMed
  5. Ostrosky-Zeichner L, Rex JH, Bennett J, Kullberg BJ. Deeply invasive candidiasis. Infect Dis Clin North Am. 2002 Dec;16(4):821-35. | CrossRef | PubMed
  6. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of Nosocomial Candidemia on Outcomes of Critically Ill Patients. Am J Med. 2002 Oct 15;113(6):480-5. | CrossRef | PubMed
  7. Martino R, Subirà M. Invasive fungal infections in haematology: new trends. Ann Hematol. 2002 May;81(5):233-43. Epub 2002 May 4. | CrossRef | PubMed
  8. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005 Mar;31(3):393-400. Epub 2005 Feb 12. | CrossRef | PubMed
  9. Petri MG, König J, Moecke HP, Gramm HJ, Barkow H, Kujath P, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med. 1997 Mar;23(3):317-25. | CrossRef | PubMed
  10. Colombo AL, Perfect J, DiNubile M, Bartizal K, Motyl M, Hicks P, et al. Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis. Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):470-4. Epub 2003 Jul 23. | CrossRef | PubMed
  11. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, et al. The Epidemiology of Candida glabrata and Candida albicans Fungemia in Immunocompromised Patients With Cancer. Am J Med. 2002 Apr 1;112(5):380-5. | CrossRef | PubMed
  12. Iwen PC. Molecular detection and typing of fungal pathogens. Clin Lab Med. 2003 Dec;23(4):781-99. | CrossRef | PubMed
  13. Lepper PM, Wiedeck H, Geldner G, Essig A, Trautmann M. Value of Candida Antigen and Antibody assays for the diagnosis of invasive candidacies in surgical intensive care patients. Intensive Care Med. 2001 May;27(5):916-20. | CrossRef | PubMed
  14. O'Shaughnessy EM, Shea YM, Witebsky FG. Laboratory diagnosis of invasive mycoses. Infect Dis Clin North Am. 2003 Mar;17(1):135-58. | CrossRef | PubMed
  15. Salavert Lletí M, Jarque Ramos I, Pemán García J. Aspectos Epidemiológicos Cambiantes de la Candidemia y sus Implicaciones Clínico-Terapéuticas. Enferm Infecc Microbiol Clin. 2006 Oct;24 Suppl 1:36-45. | CrossRef | PubMed
  16. Peláez García MT, Alcalá Hernández L, Muñoz García P, Bouza Santiago E. Nuevos antifúngicos. Medicine. 1998; 7(91):4251-4262.
  17. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006 Mar;34(3):646-52. | CrossRef | PubMed
  18. Hay RJ. Antifungal drugs used for systemic mycoses. Dermatol Clin. 2003 Jul;21(3):577-87. | CrossRef | PubMed
  19. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in non neutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 2002 Dec;28(12):1708-17. Epub 2002 Nov 1. | CrossRef | PubMed
  20. Silvestri L, van Saene HK, Milanese M, Gregori D. Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials Intensive Care Med. 2005 Jul;31(7):898-910. Epub 2005 May 14. | CrossRef | PubMed
  21. Ho KM, Rochford SA, John G. The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: A meta-analysis. Crit Care Med. 2005 Oct;33(10):2383-92. | CrossRef | PubMed
  22. Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patients Lancet Infect Dis. 2003 Dec;3(12):772-85. | CrossRef | PubMed
  23. Dismukes WE. Introduction to Antifungal Drugs. Clin Infect Dis. 2000 Apr;30(4):653-7. Epub 2000 Apr 20. | CrossRef | PubMed
  24. Andes D. Clinical pharmacodynamics of antifungals Infect Dis Clin North Am. 2003 Sep;17(3):635-49. | CrossRef | PubMed
  25. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for Treatment of Candidiasis. Clin Infect Dis. 2004 Jan 15;38(2):161-89. Epub 2003 Dec 19. | CrossRef | PubMed
  26. Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, et al. Assessment of pre-emptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med. 2004 Dec;32(12):2443-9. | CrossRef | PubMed
  27. Gupta AK, Tomas E. New antifungal agents. Dermatol Clin. 2003 Jul;21(3):565-76. | CrossRef | PubMed
  28. Fleming RV, Walsh TJ, Anaissie EJ. Anaissiec. Emerging and less common fungal pathogens. Infect Dis Clin North Am. 2002 Dec;16(4):915-33, vi-vii. | CrossRef | PubMed
  29. Bidart T. Rol de voriconazol y caspofungina en terapia antifúngica, Rev Chil Infect. 2004;21(Supl 1):S7-S12. | CrossRef
  30. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections, Mycology. Lancet Infect Dis. 2003 Apr;3(4):230-40. | CrossRef | PubMed
  31. Roilides E, Lyman CA, Panagopoulou P, Chanock S. Immunomodulation of invasive fungal infections. Infect Dis Clin North Am. 2003 Mar;17(1):193-219. | CrossRef | PubMed
  32. Baddley JW, Moser SA. Emerging fungal resistance. Clin Lab Med. 2004 Sep;24(3):721-35, vii. | CrossRef | PubMed
  33. Masiá Canuto M, Gutiérrez Rodero F. Antifungal drug resistance to azoles and polyenes Lancet Infect Dis. 2002 Sep;2(9):550-63. | CrossRef | PubMed
  34. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences Lancet Infect Dis. 2002 Feb;2(2):73-85. | CrossRef | PubMed
  35. Procop GW, Roberts GD. Emerging fungal diseases: the importance of the host. Clin Lab Med. 2004 Sep;24(3):691-719, vi-vii. | CrossRef | PubMed
  36. Playford EG, Sorrell TC. Optimizing therapy for Candida infections. Semin Respir Crit Care Med. 2007 Dec;28(6):678-88. | CrossRef | PubMed